News
A Slight Increase in Pediatric Cancer Risk Seen with Infant Phototherapy
Phototherapy, increasingly used to treat jaundiced infants, could very slightly raise the risk of pediatric cancers, particularly myeloid leukemia, according to epidemiological research published online on May 23 in Pediatrics. At very high levels, bilirubin, a byproduct of the normal breakdown of
Better Survival for Colon Cancer Patients with Left-Sided Tumors
The chances of surviving colon cancer could depend on which side of the colon the cancer strikes. A national study led by a UC San Francisco oncologist has found that patients with metastatic colon cancer that develops on the left side of the colon survive significantly longer than those with
Hybrid Cancer Drug Could Be Resistance-Resistant
A team of cancer researchers led by scientists at UC San Francisco and Memorial Sloan Kettering Cancer Center demonstrated in human cells and mouse models that a first-of-its-kind hybrid drug can outsmart drug-resistant cancers. The new drug physically yokes together two existing drugs against a
Trever Bivona, Pamela Ling Elected to American Society for Clinical Investigation
Five UC San Francisco faculty members have been elected to the American Society for Clinical Investigation (ASCI) after a highly competitive nomination process. The ASCI, which is one of the oldest medical honor societies in the United States, received 160 membership nominations for 2016 and
Laura Esserman Named to TIME 100 List of Most Influential People in the World
Time magazine has named internationally renowned breast cancer oncologist Laura Esserman, MD, MBA, to the 2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world. Esserman has been at the forefront of efforts to change the delivery of breast cancer services as well
New UCSF Center for BRCA Research Expands Care for Increased Cancer Risk
As more people get their hands on their own genetic data each day, many face an increasingly common question: What do you do if you carry a genetic risk factor for cancer? While knowing genetic mutations can help clinicians decide on treatment options for patients, the data raises more questions
Stand Up To Cancer Supports Innovative Research Grants for 10 Early-Career Scientists
NEW ORLEANS — Stand Up To Cancer (SU2C) announced Monday that it is awarding 10 grants of $750,000 each to early-career scientists to support innovative, high-risk, high-reward projects in cancer research. The announcement was made at the 2016 Annual Meeting of the American Association for Cancer